Abstract-Reactive oxygen species (ROS) hydrogen peroxide (H 2 O 2 ) and hypochlorite (HOCl) (ECs). Changes in the level of EC cGMP (the second messenger of NO) were used as a surrogate of NO production. EC cGMP increased 300% in response to bradykinin and A23187 and 200% in response to ADP. Exposure of ECs to H 2 O 2 (50 mol/L) for 30 minutes significantly impaired cGMP levels in response to ADP, bradykinin, and the receptor-independent NO agonist A23187. In contrast, preincubation with HOCl (50 mol/L) impaired cGMP production only in response to ADP and bradykinin but not A23187. These concentrations of H 2 O 2 and HOCl did not result in increased EC lethality as assessed by lactate dehydrogenase release. Neither H 2 O 2 nor HOCl affected EC cGMP production in response to NO donor sodium nitroprusside, which suggests that guanylate cyclase is resistant to these oxidants. We also demonstrated that neither H 2 O 2 nor HOCl affects endothelial NO synthase (eNOS) catalytic activity as measured by conversion of L-arginine to L-citrulline in EC homogenates supplemented with eNOS cofactors. The present studies show that H 2 O 2 impairs NO production in response to both receptor-dependent and receptor-independent agonists and that these effects are due, at least in part, to inactivation of eNOS cofactors, whereas HOCl inhibits NO production by interfering with receptor-operated mechanisms at the level of the cell membrane. Concentrations of H 2 O 2 and HOCl used in the present studies have been shown to be generated in vivo during inflammation and ischemia/reperfusion. Therefore, we infer that these effects of H 2 O 2 and HOCl on EC NO production may contribute to disregulated vascular tone and altered leukocyte-EC interactions that occur in vascular injury as a result of those causes in which ROS generation is involved. (Hypertension. 2001;38:877-883.)
V ascular injury secondary to processes such as ischemia/ reperfusion, inflammation, and atherosclerosis is accompanied by synthesis and release of reactive oxygen species (ROS). 1 Among the ROS generated are hydrogen peroxide (H 2 O 2 ), hypochlorite (HOCl), hydroxyl, and superoxide (O 2 Ϫ ). 2 These oxidants can induce injury in a variety of mammalian cells, including endothelial cells (ECs). 3 Although O 2 Ϫ can be directly toxic, it has limited reactivity with most biological molecules. 4 However, O 2 Ϫ can dismutate either spontaneously or through superoxide dismutase to H 2 O 2 5 . Therefore, H 2 O 2 almost always is formed under any circumstance in which O 2 Ϫ is produced. 5 Acting as an electron donor, O 2 Ϫ also can lead to generation of hydroxyl radical through an O 2 Ϫ -driven Fenton reaction, 6 and by interaction with NO, O 2 Ϫ can generate highly reactive peroxynitrite. 7 No direct interaction has been described for NO with H 2 O 2 or HOCl.
H 2 O 2 diffuses freely into cells to produce several biochemical perturbations, including activation of the hexose monophosphate shunt and glutathione redox cycles, 8 oxidation of intracellular sulfhydryls, 9 depression of intracellular ATP, 10 DNA damage, 11 loss of intracellular ␤-nicotinamide adenine dinucleotide, 12 activation of poly(ADP-ribose) polymerase, 13 fast rise of intracellular calcium, 8 gross perturbations to the cytoskeleton and plasma membrane, 14 and depression in glycolytic flux. 15 All of these processes occur before loss of membrane integrity as measured by vital stains 8 or before loss of preloaded Cr 51 . 11 Myeloperoxidase, a heme protein secreted by phagocytes, amplifies the oxidative potential of H 2 O 2 by generating cytotoxic oxidants and diffusible radical species. 16 The major oxidant generated by the myeloperoxidase-H 2 O 2 -Cl Ϫ system at physiological concentrations of Cl Ϫ is HOCl. 17 Toxic properties of HOCl stem from its chemical reactivity, including oxidative bleaching of heme groups and iron-sulfur centers 16 and chlorination of amines 18 and unsaturated lipids. 19 However, in contrast to H 2 O 2 , HOCl is less diffusible and interacts mainly with cellular membrane components, oxidizing plasma membrane sulfhydryl groups 20 and disturbing cellular functions such as glucose and amino acid transporters and potassium pumping capacity. 21 Endothelial NO synthase (eNOS) is located in small invaginations of the plasma membrane called caveolae 22 and produces NO in response to a variety of agonists. Acetylcholine, adenosine nucleotides such as ADP, and bradykinin (BK) stimulate NO synthesis through receptor-operated mechanisms, whereas calcium ionophore A23187 leads to NO synthesis by stimulating calcium fluxes through receptorindependent mechanisms. 23 NO activates guanylate cyclase in an autocrine fashion within the endothelium and in a paracrine fashion in vascular smooth muscle (VSM), which results in increased intracellular cGMP. 23 The amount of cGMP generated is proportional to the amount of NO and, therefore, is an indirect measurement of NO bioactivity. 23 Although increased cGMP in VSM is linked to relaxation, the role of endothelial cGMP has remained more obscure.
Experimentally, ischemia/reperfusion of the heart 24 and kidney 25 results in increased generation of ROS and decreased endothelial NO bioactivity as evidenced by impaired endothelium-dependent relaxation to acetylcholine and BK, known agonists of NO. 25 Furthermore, topical H 2 O 2 has been shown to eliminate endothelium-dependent vasodilatory response to acetylcholine in cerebral circulation. 26 After ischemia/reperfusion, decreased NO bioactivity is not accompanied by a reduction in eNOS as demonstrated by histochemical methods. 25 In addition, infusion of angiotensin (Ang) II into rats results in hypertension accompanied by increased production of O 2 Ϫ in the aorta. 27 We used several strategies to study the effect of nonlethal concentrations of the ROS H 2 O 2 and HOCl on EC NO synthesis. First, we studied the effect of H 2 O 2 and HOCl on EC cGMP production. In our laboratory, it has been difficult to obtain consistent measurements of small quantities of NO generated from cultured ECs. Therefore, we used cGMP production within the same ECs as a surrogate of NO generation. 28 This approach also permitted us to evaluate the effect of ROS on guanylate cyclase. Second, we studied the effect of H 2 O 2 and HOCl on eNOS catalytic activity by measuring the conversion of C 14 L-arginine to C 14 L-citrulline in homogenates of ECs previously exposed to these ROS. Third, we determined the effect of these ROS on eNOS catalytic activity in homogenates of ECs and fourth, the effect of these ROS on individual eNOS cofactors.
Methods

EC Culture
ECs were isolated from fresh porcine aorta by incubating the lumen of the vessels in type II collagenase (2 mg/mL; Sigma Chemical Co) at 37°C for 20 minutes. Aortas were rinsed with medium 199 (Cellgro, Mediatech) supplemented with 10% FCS (HyClone) and cells plated directly into 6-well culture dishes (Costar). Cells were identified as endothelial by their morphology and positive uptake of fluorescent acetylated LDL.
Cell Incubation
ECs were washed and preincubated with Krebs-Ringer bicarbonate buffer that contained 3-isobutyl- mol/L; Sigma). Sodium nitroprusside (SNP; 10 Ϫ3 mol/L) also was tested. At the end of 3 minutes' incubation, intracellular cGMP was measured by radioimmunoassay as previously described. 29 cGMP per well was factored for protein content measured by the method of Lowry et al. 30 The following experiments were performed to confirm that changes in EC cGMP in response to agonists of NO were due to autocrine effects of endothelial NO. mol/L), were added to cells preincubated in standard and L-argininedepleted medium; cGMP was measured as described above.
Effect of Oxidant Injury on EC cGMP Synthesis
To induce oxidant injury, ECs were preincubated with either H 2 O 2 (50 mol/L) or HOCl (50 mol/L) (Sigma) for 30 minutes before incubation with NO agonist or corresponding vehicle. After incubation with NO agonist, cGMP was measured as described above.
Effect of Oxidant Injury on NOS Activity
To determine the direct effect of oxidant injury on eNOS, ECs were preincubated with either H 2 O 2 (50 mol/L) or HOCl (50 mol/L) for 30 minutes, and eNOS activity was determined in vitro in homogenates of ECs. In separate experiments, homogenates of ECs were exposed to H 2 O 2 (50 mol/L) or HOCl (50 mol/L) for 30 minutes and eNOS activity determined in the presence of optimal amounts of NOS cofactors ( Figure 1 ). In other experiments, individual NOS cofactors were exposed to H 2 O 2 (50 mol/L) or HOCl (50 mol/L) for 30 minutes and then added to homogenates of ECs for eNOS activity determination. NOS activity was measured as previously described 31 ( Figure 1 ). 
Statistical Analysis
Results
NO Agonists Increase EC cGMP Synthesis
ECs exposed for 30 minutes to the NO agonists A23187, ADP, or BK showed increased cGMP compared with that of control ( Figure 2 ). NOS inhibitor L-NMMA (10 Ϫ4 mol/L) significantly inhibited cGMP production stimulated by these agonists (Figure 2 ).
Arginine Depletion Diminishes EC cGMP Production in Response to NO Agonists
Twenty-four hours of L-arginine depletion lowered basal levels of cGMP slightly but not significantly from 8.5Ϯ2.5 to 5.8Ϯ0.5 fmol/g of protein (nϭ3; PϭNS). L-arginine depletion significantly blunted cGMP production stimulated by A23187: for cells in standard medium with A23187, cGMP level was 27.4Ϯ2.0 fmol/g of protein (nϭ3); in L-argininedepleted medium with A23187, cGMP level was 11.8Ϯ0.40 fmol/g of protein (nϭ3, PϽ0.05).
Thus, elimination of L-arginine, the substrate of eNOS, from the culture medium or inhibition of NO synthesis with L-NMMA significantly prevented increases in EC cGMP induced by NO agonists, thereby establishing that observed increases in EC cGMP are a result of increased EC NO.
H 2 O 2 Impairs EC cGMP Production in Response to NO Agonists
As shown in Figure 3 , H 2 O 2 preexposure for 30 minutes significantly impaired increases in EC cGMP synthesis in response to all NO agonists tested. These changes in cGMP production were not accompanied by increased EC lethality as assessed by LDH release (0% release). However, H 2 O 2 preexposure did not significantly affect EC cGMP production stimulated by the exogenous NO donor SNP (Figure 3 ). This occurrence suggests that H 2 O 2 did not affect EC guanylate cyclase levels. (Figure 4 ). These changes in cGMP production were not accompanied by increased EC lethality as assessed by LDH release (0% release). However, in contrast to H 2 O 2 , A23187-stimulated production of cGMP was not significantly affected by preexposure of EC to HOCl (Figure 4) . In a manner similar to H 2 O 2 , HOCl did not affect SNP-stimulated cGMP production ( Figure 4) . 
HOCl Impairs EC cGMP Production in
Exposure of ECs to H 2 O 2 or HOCl Does Not Affect Intrinsic Catalytic Activity of eNOS
To explore whether observed effects of H 2 O 2 and HOCl on NO production were due to oxidative damage of eNOS or oxidation of the necessary cofactors for optimal eNOS activity, we determined eNOS activity in cell homogenates from ECs preexposed to H 2 O 2 or HOCl in which all eNOS cofactors were added from exogenous sources. As shown in Figure 5 , eNOS activity was similar in control ECs and ECs preexposed to H 2 O 2 (50 mol/L) for 30 minutes. These findings suggest that effects of H 2 O 2 on NO production are because of a direct effect of H 2 O 2 on eNOS cofactors and not on total eNOS catalytic activity. As expected, eNOS catalytic activity in ECs pretreated with HOCl was also preserved, consistent with the notion that effects of HOCl are at a relatively early point in signal transduction (cell membrane), whereas eNOS and its cofactors are spared from HOClinduced oxidative damage ( Figure 5 ).
To demonstrate a direct effect of H 2 O 2 on eNOS cofactors, individual eNOS cofactors were exposed to H 2 O 2 (50 mol/L) and then added to the purified enzyme before eNOS catalytic activity was measured. 
PϽ0.05 versus control
Discussion
A growing body of evidence implicates NO as an important modulator of vascular tone and architecture as well as of adhesive interactions between leukocytes, platelets, and vascular endothelium. 32 Processes of ischemia/reperfusion and atherosclerosis are characterized by increased adhesion of leukocytes and platelets to the vascular endothelium 33 as a result of increased adhesion-molecule expression. 34 The latter has been attributed to diminished bioactivity of NO and increased production of ROS such as H 2 O 2 and O 2 Ϫ . 35 O 2 Ϫ in the extracellular milieu, given its great affinity for NO, rapidly interacts with this molecule and results in NO inactivation and/or production of toxic peroxynitrite. 7 No direct interaction between H 2 O 2 and NO has been described.
ROS generation may be a common pathway for many types of pathological processes. Several ROS including H 2 O 2 and O 2 Ϫ are produced by leukocytes after perturbation of their membranes as part of the respiratory burst 36 or by vascular endothelium during the reperfusion period after ischemic injury. 2 In addition, O 2 Ϫ is generated by Ang II-mediated activation of NADH/NADPH oxidase by the AT 1 receptor in VSM cells, 27,37 vascular ECs, 38 and glomerular mesangial cells. 39 39, 40 and proliferation. 41 These actions of Ang II are believed to be important to explain the role of Ang II in pathological vascular remodeling in hypertension 42, 43 and in atherosclerosis. 44 A study recently reported that antioxidants restore endothelial function and decrease blood pressure in animal models of hypertension. 45 Hyperlipidemia in rabbits is associated with increased AT 1 receptor density and increased O 2 Ϫ production derived from NADH/NADPH oxidase. 46, 47 In humans with atherosclerosis, AT 1 receptor blockade improves endothelium-dependent relaxation mediated by NO. 48 On the other hand, NO has been shown to have an inhibitory effect on NADH/NADPH oxidase 49 and to downregulate Ang II receptors in VSM cells. 50 H 2 O 2 generation is followed by generation of other toxic molecules, including HOCl. 17 When H 2 O 2 is formed by polymorphonuclear cells in vivo, up to 40% is halogenated by myeloperoxidase into HOCl and in acidic conditions into Cl 2 , 51 which also has oxidant activity and may be implicated in several oxidative and cytotoxic reactions at sites of inflammation and vascular disease. 51 Furthermore, the myeloperoxidase-H 2 O 2 -chloride system of phagocytes 52 promotes the formation of advanced glycation end products, 53 which play an active role in the pathogenesis of atherosclerosis. 54 ADP and BK are 2 agonists of NO that bind to receptors located on the EC membrane, whereas A23187 is a calcium ionophore that induces NO synthesis and release, directly promoting a calcium influx into ECs, which activates eNOS. 23 The present studies show that exposure of ECs to nonlethal concentrations of H 2 O 2 and HOCl impairs endothelial NO production in response to several NO agonists, as evidenced by decreased production of cGMP, the intracellular NO second messenger. H 2 O 2 impairs NO synthesis in response to receptor-dependent (BK and ADP) and receptorindependent agonists (A23187), which suggests that H 2 O 2 may affect eNOS catalytic action or eNOS cofactors. However, we found that the catalytic activity of eNOS in extracts from ECs exposed to H 2 O 2 and activated in the presence of exogenously added cofactors is similar to that in control ECs not exposed to this oxidant. On the other hand, exposure of eNOS cofactors to H 2 O 2 before such cofactors are added to EC homogenates resulted in impaired eNOS activity. These findings suggest that H 2 O 2 affects oxidant-sensitive eNOS cofactors but not the intrinsic catalytic activity of eNOS. Among the eNOS cofactors, FMN was the most sensitive to oxidation by H 2 O 2 , whereas other eNOS cofactors, including BH4, were less sensitive. Similar findings with BH4 have been previously reported by Milstien and Katusik. 55 In the aggregate, these findings support our previous studies in a rat model of ischemia/reperfusion acute renal failure that demonstrated preserved eNOS activity in the renal vasculature despite decreased NO bioactivity. 25 Similar findings also have been reported in a model of lead-induced hypertension. 56 In contrast to H 2 O 2 , HOCl impaired responses only to the receptor-dependent agonists BK and ADP. The response was preserved to the calcium ionophore and the eNOS catalytic activity in homogenates of ECs obtained after HOCl exposure. These results with intact cells are consistent with the notion that HOCl affects specific plasma membrane targets and impairs EC production of NO at a relatively early point in receptor-operated signal transduction. 16 eNOS is located in small invaginations of the plasma membrane called caveolae. 22 We speculate that HOCl may be affecting eNOScaveolae interaction, resulting in impaired receptordependent NO production. 57 On the other hand, exposure of eNOS cofactors or EC homogenates to HOCl resulted in impaired eNOS catalytic activity. Because of the high reactivity of HOCl, its reactions are dependent on the relative concentration and reactivities of compounds in the immediate vicinity of where it is produced. 16 In intact ECs, the closest targets for HOCl to react are the sulfhydryl groups of the cell membrane; however, in the absence of cell membranes, HOCl can react with multiple targets, including eNOS cofactors or eNOS itself, resulting in impaired eNOS activity.
Neither HOCl nor H 2 O 2 blunted SNP-stimulated cGMP production by ECs, which suggests that guanylate cyclase can withstand the oxidative stress imposed by these agents. Moreover, the preserved response to SNP and the lack of LDH release by ECs exposed to H 2 O 2 or HOCl provide strong evidence that cell viability was not affected by exposure to these oxidants.
The present studies suggest that ROS such as H 2 O 2 and HOCl contribute to decreased NO bioactivity observed in vascular ischemia/reperfusion processes and, perhaps, in 
